Oral DS107 in Moderate to Severe Atopic Dermatitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

This study will compare the safety and efficacy of Oral DS107 (2 g) to placebo in patients with moderate to severe atopic dermatitis. Oral DS107 (2 g) will be orally administered for 8 weeks, and will be compared against placebo. This study will enroll approximately 100 adult patients.

Key facts

Study ID

NCT02211417

Run by

Dignity Sciences Ltd.

People needed

102

Starts

2015-01-01

Expected to finish

2015-12-01

Last updated by the study team

2022-10-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subject aged 18 years and older.
• Moderate to severe atopic dermatitis.

You may not qualify if…

• Clinically significant impairment of renal or hepatic function.
• History of hypersensitivity to any substance in Oral DS107 or placebo capsules.
• Treatment with any experimental drug within 30 days prior to Day 0 visit (baseline).
• Excessive sun exposure, use of tanning booths or other ultraviolet (UV) light sources and/or is planning a trip to sunny climate.

Where it is running

• Dignity Sciences investigational site — Arlington Heights, Illinois, United States
• Dignity Sciences investigational site — West Dundee, Illinois, United States
• Dignity Sciences investigational site — Warren, Michigan, United States
• Dignity Sciences investigational site — Verona, New Jersey, United States
• Dignity Sciences investigational site — New York, New York, United States
• Dignity Sciences investigational site — Rochester, New York, United States
• Dignity Sciences investigational site — Hazleton, Pennsylvania, United States
• Dignity Sciences investigational site — Philadelphia, Pennsylvania, United States
• Dignity Sciences investigational site — Calgary, Alberta, Canada
• Dignity Sciences investigational site — Edmonton, Alberta, Canada
• Dignity Sciences investigational site — Markham, Ontario, Canada
• Dignity Sciences investigational site — Windsor, Ontario, Canada
• Dignity Sciences investigational site — Drummondville, Quebec, Canada
• Dignity Sciences investigational site — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.